Atjaunināt sīkdatņu piekrišanu

E-grāmata: Globalization of China's Health Industry: Industrial Policies, International Networks and Company Choices

, , ,
Citas grāmatas par šo tēmu:
  • Formāts - EPUB+DRM
  • Cena: 213,54 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
Globalization of China's Health Industry: Industrial Policies, International Networks and Company ChoicesPalielināt
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

This book explores the ongoing transition of China’s economy by examining how its healthcare industry is growing and changing. The coronavirus pandemic has reinforced one of the authors' key points: in our complex, fragile, and interconnected societies, the production of health is a vital strategic ‘industry’. The case of China is particularly salient, because of its economic and geopolitical significance, and the scale of the healthcare challenge it has faced.

Adopting a multi-level perspective, the authors examine the entrepreneurial role of the Chinese government as it seeks to strengthen the competitiveness of domestic firms. They analyze the strategies employed to improve China’s technology and capacity for innovation, and discuss China’s strategies and policies to ensure knowledge acquisition and creation in the long-term, with particular reference to international scientific collaborations. This book is a must-read for students, researchers, and policymakers interested in the prospects and challenges posed by the growth of the Chinese healthcare industry and its global impact. 

1 On Health Production and Demand: And Why an Effective Health Industry is Vital for China (and the Rest of the World)
1(42)
1.1 Introduction
1(1)
1.2 Health, Economic Productivity and Growth
2(9)
1.3 Health, Development and Structural Change Sustainability
11(4)
1.4 Health, People's Satisfaction and Political Consensus
15(3)
1.5 On the Desirable and Acceptable Level of Health
18(7)
1.6 Health is Not Like Other Simple (Private) Goods
25(1)
1.7 The Value of Producing Health: Big Data
26(3)
1.8 The Health Industry Perspective
29(14)
1.8.1 The Main Actors in the Health Industry
30(6)
References
36(7)
2 The Rise of China as a Global Player in the Healthcare Industry
43(26)
2.1 Understanding China
43(5)
2.2 Healthcare and China 2025 Plan
48(1)
2.3 Healthcare and the Belt and Road Initiative
49(1)
2.4 Reforms and Numbers: The New Role of China on the Global Stage
50(19)
2.4.1 The Pharmaceutical Industry
51(5)
2.4.2 The Medical Equipment Industry
56(1)
2.4.3 The Traditional Chinese Medicine Industry
57(7)
References
64(5)
3 Government Planning and Policy for the Health Industry
69(30)
3.1 Introduction
69(3)
3.2 A Brief Review of Major Health Reforms in PRC
72(6)
3.3 Reforms at Work: Plans and Policies for the Health Industry
78(21)
3.3.1 A Brief Introduction to the Institutional Setting
78(1)
3.3.2 Health as a Strategic Sector in the National Development Plans
79(4)
3.3.3 Development Plans for the Health Industry
83(1)
3.3.3.1 Biotechnology Industry
83(2)
3.3.3.2 Traditional Chinese Medicine
85(2)
3.3.3.3 Pharmaceutical Industry
87(3)
3.3.4 Zooming on the Pharmaceutical Sector: Restructuring Through M&A
90(4)
References
94(5)
4 The Globalization of the Industry: Chinese Inward and Outward FDIs
99(42)
4.1 Introduction
99(1)
4.2 China and Health Industry: A Changing Competitive Landscape
100(2)
4.3 Opening the Door to International Investors: The Role of Western Multinationals in China
102(13)
4.3.1 The Pharmaceutical Industry
103(6)
4.3.2 The Medical Device Industry
109(1)
4.3.3 The Role of Foreign Investors
110(5)
4.4 The Globalization of Chinese Firms
115(5)
4.4.1 The Go Global Strategy
115(1)
4.4.2 A World Map of Chinese Investments
116(1)
4.4.3 A Focus on Chinese Investments in the EU
117(3)
4.5 Learning from Cases of Chinese and Western International Firms
120(8)
4.5.1 Foreign Acquisition of Chinese Firms
120(3)
4.5.2 Chinese Firms Investing Abroad
123(5)
4.6 The Internationalization of Chinese Industry: Challenges and Issues
128(13)
References
134(7)
5 Innovation and Research Excellence: China in the International Scientific Scenario
141(22)
5.1 China's Focus on Research
141(5)
5.2 China's Presence in the International Scientific Scenario
146(1)
5.3 Chinese Research and International Cooperation
147(8)
5.3.1 China's Transnational Relations in Health
153(2)
5.4 Quality of Chinese Research
155(8)
References
159(4)
6 Challenges for the Future and the Role of Industrial Policy
163(22)
6.1 Introduction
163(2)
6.2 Challenges for the Future of Chinese Healthcare
165(9)
6.2.1 Accessibility of Services
165(3)
6.2.2 Pollution
168(1)
6.2.3 Innovation and Industry
169(3)
6.2.4 Health Industry and Trade War
172(2)
6.3 Industrial Policy and Healthcare Reforms
174(3)
6.4 Internal Weaknesses and Global Issues: Lessons from the Coronavirus Epidemic
177(8)
References
178(7)
Index 185
Marco R. Di Tommaso is Full Professor of Applied Economic Studies, University of Ferrara, Italy, and Director of c.MET05 - The National University Centre for Applied Economic Studies, Italy. He is also a Life Member Fellow at Clare Hall, University of Cambridge, UK, and Honorary Professor at the South China University of Technology and the South China Normal University.





Francesca Spigarelli is Associate Professor of Applied Economic Studies at the University of Macerata, Italy, where she is Director of the China Center, and Vice Rector for Entrepreneurship and Technological Transfer and for European Research Policy. She is also a member of the c.MET05 Steering Board. 





Elisa Barbieri is Associate Professor of Applied Economic Studies at the Ca Foscari University of Venice, Italy; Senior Researcher and a member of the Steering Board at c.MET05. She is Associate Editor for the journals Competition and Change and lIndustria.





Lauretta Rubini is Associate Professor of Applied Economic Studies and Coordinator of the Master's Degree Programmes at the Department of Economics and Management of the University of Ferrara, Italy. She is also Visiting Scholar at the University of California Los Angeles, USA, and Senior Researcher and a member of the Steering Board at c.MET05.
Biežāk uzdotie jautājumi par e-grāmatām Biežāk uzdotie jautājumi par e-grāmatām
Permanent link: https://www.kriso.lv/db/97830304667186e.html
Keywords: